These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3144731)

  • 1. [Blockade of the inhibitory effect of Clostridium perfringens alpha toxin on cytochrome P-450 using Edtacal].
    Klein O; Fiserová M; Soucek A
    Sb Lek; 1988 Oct; 90(10):297-301. PubMed ID: 3144731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of cytochrome P-450 and cytochrome b5 induced by Clostridium perfringens alpha toxin].
    Klein O; Fiserová M; Soucek A
    Sb Lek; 1988 Oct; 90(10):291-6. PubMed ID: 2905072
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum inhibitors of Clostridium perfringens alpha toxin].
    Strnad V; Sobek V; Soucek A
    Cesk Epidemiol Mikrobiol Imunol; 1986 Apr; 35(2):102-7. PubMed ID: 2938745
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraperitoneal fluid accumulation induced by Clostridium perfringens alpha-toxin (phospholipase C).
    Maegawa T; Wang X; Karasawa T; Zuka M; Kita H; Nakamura S
    Acta Microbiol Pol; 2002; 51(4):387-9. PubMed ID: 12708827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variation in the alpha-toxin encoding plc gene of Clostridium perfringens strains isolated from diseased and healthy chickens.
    Abildgaard L; Engberg RM; Pedersen K; Schramm A; Hojberg O
    Vet Microbiol; 2009 May; 136(3-4):293-9. PubMed ID: 19070974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of erythromycin on biological activities induced by clostridium perfringens alpha-toxin.
    Oda M; Kihara A; Yoshioka H; Saito Y; Watanabe N; Uoo K; Higashihara M; Nagahama M; Koide N; Yokochi T; Sakurai J
    J Pharmacol Exp Ther; 2008 Dec; 327(3):934-40. PubMed ID: 18794379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium perfringens alpha-toxin: characterization and mode of action.
    Sakurai J; Nagahama M; Oda M
    J Biochem; 2004 Nov; 136(5):569-74. PubMed ID: 15632295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells.
    Steinthorsdottir V; Halldórsson H; Andrésson OS
    Microb Pathog; 2000 Jan; 28(1):45-50. PubMed ID: 10623563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rate of pentobarbital and acetanilide metabolism by liver microsomes: a function of lipid peroxidation and degradation of cytochrome P-450 heme.
    Jacobson M; Levin W; Lu AY; Conney AH; Kuntzman R
    Drug Metab Dispos; 1973; 1(6):766-74. PubMed ID: 4156299
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of p-amino-diphenyl ethers on hepatic microsomal cytochrome P450.
    Jiang H; Xuan G
    Pharmazie; 2003 Sep; 58(9):654-6. PubMed ID: 14531464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats.
    Sakurai J; Oshita Y; Fujii Y
    Toxicon; 1985; 23(6):903-12. PubMed ID: 4095705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens.
    Basak AK; Stuart DI; Nikura T; Bishop DH; Kelly DC; Fearn A; Titball RW
    J Mol Biol; 1994 Dec; 244(5):648-50. PubMed ID: 7990145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridial enteropathy in lactating outbred swiss-derived (ICR) mice.
    Krugner-Higby L; Girard I; Welter J; Gendron A; Rhodes JS; Garland T
    J Am Assoc Lab Anim Sci; 2006 Nov; 45(6):80-7. PubMed ID: 17089998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous two-phase systems extraction of alpha-toxin from Clostridium perfringens type A.
    Cavalcanti MT; Porto TS; de Barros Neto B; Lima-Filho JL; Porto AL; Pessoa A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 833(2):135-40. PubMed ID: 16513438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Clostridium difficile toxins and mouse hepatic microsomes.
    Ehrich M
    Toxicon; 1983; 21(6):903-7. PubMed ID: 6658814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of plc gene transcription and alpha-toxin production during growth of Clostridium perfringens strains with contrasting alpha-toxin production.
    Abildgaard L; Schramm A; Rudi K; Højberg O
    Vet Microbiol; 2009 Oct; 139(1-2):202-6. PubMed ID: 19559545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.